Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Medtronic
McKesson
Harvard Business School
Colorcon

Last Updated: December 3, 2021

DrugPatentWatch Database Preview

Litigation Details for Merck Sharp & Dohme Corp. v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2019)


Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in Merck Sharp & Dohme Corp. v. Mylan Pharmaceuticals Inc.
The small molecule drugs covered by the patents cited in this case are ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , and ⤷  Try it Free .

Details for Merck Sharp & Dohme Corp. v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2019)

Date Filed Document No. Description Snippet Link To Document
2019-05-02 1 Complaint (NOT for attorney use) expiration of U.S. Patent No. 7,326,708 ("the '708 patent") and U.S. Patent No. 8,414,921 (… the '708 patent, including claim 1 of the '708 patent, and the '708 patent has been listed… the '708 patent, including claim 1 of the '708 patent, and the '708 patent has been listed… the '921 patent, including claim 1 of the '921 patent, and the '921 patent has been listed…(Attachments: # 1 Exhibit A - Patent Information, # 2 Exhibit B - Patent Information, # 3 Civil Cover External link to document
2021-01-04 54 Status Report 17, 19, and 21–23 of U.S. Patent No. 7,326,708. On May 12, 2020, the Patent Trial & Appeal Board …opinion construing certain terms of U.S. Patent Nos. 7,326,708, and 8,414,921. IPR2020-00040: …Order centralizing pretrial proceedings in this patent infringement litigation in the District of Delaware…Board instituted trial on Mylan’s petition. Merck’s patent owner’s response pursuant to 35 U.S.C. § 316(a…2019 9 August 2019 1:19-cv-00101 830 Patent None District Court, N.D. West Virginia External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
McKesson
Medtronic
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.